Back to Search Start Over

Improved Survival in Liver Transplant Recipients Receiving Prolonged-Release Tacrolimus in the European Liver Transplant Registry

Authors :
Paolo Muiesan
Safi Dokmak
Otto Kollmar
Bo-Göran Ericzon
Marek Krawczyk
Giuseppe Tisone
Karim Boudjema
Fausto Zamboni
P. Němec
all contributing centers
R. Hanvesakul
Didier Samuel
Pavel Trunecka
Umberto Baccarani
Vincent Karam
Peter Neuhaus
Philippe Bachellier
O. Rummo
Johann Pratschke
Wolf O. Bechstein
Juergen Klempnauer
Valérie Delvart
Georges Mantion
René Adam
Massimo Rossi
Michele Colledan
Andreas Paul
Adam, R
Karam, V
Delvart, V
Trunecka, P
Samuel, D
Bechstein, W
Nemec, P
Tisone, G
Klempnauer, J
Rossi, M
Rummo, O
Dokmak, S
Krawczyk, M
Pratschke, J
Kollmar, O
Boudjema, K
Colledan, M
Ericzon, B
Mantion, G
Baccarani, U
Neuhaus, P
Paul, A
Bachellier, P
Zamboni, F
Hanvesakul, R
Muiesan, P
Source :
American Journal of Transplantation. 15:1267-1282
Publication Year :
2015
Publisher :
Elsevier BV, 2015.

Abstract

This study was a retrospective analysis of the European Liver Transplant Registry (ELTR) performed to compare long-term outcomes with prolonged-release tacrolimus versus tacrolimus BD in liver transplantation (January 2008-December 2012). Clinical efficacy measures included univariate and multivariate analyses of risk factors influencing graft and patient survival at 3 years posttransplant. Efficacy measures were repeated using propensity score-matching for baseline demographics. Patients with

Details

ISSN :
16006135
Volume :
15
Database :
OpenAIRE
Journal :
American Journal of Transplantation
Accession number :
edsair.doi.dedup.....4e61dbd7822b4c189287f596f54e5c5f